Prehospital transdermal glyceryl trinitrate in patients with ultra-acute presumed stroke (RIGHT-2): effects on outcomes at day 365 in a randomised, sham-controlled, blinded, phase III, superiority ambulance-based trial
暂无分享,去创建一个
J. Wardlaw | K. Muir | P. Bath | T. England | G. Mair | A. Siriwardena | N. Sprigg | C. Roffe | M. Randall | E. Sandset | J. Appleton | Lisa J Woodhouse | C. Price | Thompson Robinson | Sandeep Ankolekar | S. Pocock | J. Saver | Lisa J. Woodhouse
[1] C. Anderson,et al. Pre-hospital transdermal glyceryl trinitrate in patients with stroke mimics: data from the RIGHT-2 randomised-controlled ambulance trial , 2021, BMC Emergency Medicine.
[2] Peter J. Godolphin,et al. Prehospital Transdermal Glyceryl Trinitrate for Ultra-Acute Intracerebral Hemorrhage , 2019, Stroke.
[3] F. de Leeuw,et al. Multicentre Randomised trial of Acute Stroke treatment in the Ambulance with a nitroglycerin Patch (MR ASAP): study protocol for a randomised controlled trial , 2019, Trials.
[4] Peter J. Godolphin,et al. Prehospital transdermal glyceryl trinitrate in patients with ultra-acute presumed stroke ( RIGHT-2 ) : an ambulance-based , randomised , sham-controlled , blinded , phase 3 trial , 2019 .
[5] S. Pocock,et al. Ambulance-delivered transdermal glyceryl trinitrate versus sham for ultra-acute stroke: Rationale, design and protocol for the Rapid Intervention with Glyceryl trinitrate in Hypertensive stroke Trial-2 (RIGHT-2) trial (ISRCTN26986053) , 2019, International journal of stroke : official journal of the International Stroke Society.
[6] J. Wardlaw,et al. Baseline characteristics of the 1149 patients recruited into the Rapid Intervention with Glyceryl trinitrate in Hypertensive stroke Trial-2 (RIGHT-2) randomized controlled trial , 2018, International journal of stroke : official journal of the International Stroke Society.
[7] S. Pocock,et al. Tranexamic acid for hyperacute primary IntraCerebral Haemorrhage (TICH-2): an international randomised, placebo-controlled, phase 3 superiority trial , 2018, The Lancet.
[8] S. Pocock,et al. Statistical analysis plan for the ‘Rapid Intervention with Glyceryl trinitrate in Hypertensive stroke Trial-2 (RIGHT-2)’ , 2018, European stroke journal.
[9] J. Fraser,et al. Intra-arterial nitroglycerin as directed acute treatment in experimental ischemic stroke , 2016, Journal of NeuroInterventional Surgery.
[10] C. Anderson,et al. Effect of Treatment Delay, Stroke Type, and Thrombolysis on the Effect of Glyceryl Trinitrate, a Nitric Oxide Donor, on Outcome after Acute Stroke: A Systematic Review and Meta-Analysis of Individual Patient from Randomised Trials , 2016, Stroke research and treatment.
[11] J. Wardlaw,et al. Effect of Hyperacute Administration (Within 6 Hours) of Transdermal Glyceryl Trinitrate, a Nitric Oxide Donor, on Outcome After Stroke: Subgroup Analysis of the Efficacy of Nitric Oxide in Stroke (ENOS) Trial , 2015, Stroke.
[12] E. T. Investigators,et al. Efficacy of nitric oxide, with or without continuing antihypertensive treatment, for management of high blood pressure in acute stroke (ENOS): a partial-factorial randomised controlled trial , 2015, The Lancet.
[13] John M. Lachin,et al. Applications of the Wei-Lachin Multivariate One-Sided Test for Multiple Outcomes on Possibly Different Scales , 2014, PloS one.
[14] P. Bath,et al. Feasibility of an Ambulance-Based Stroke Trial, and Safety of Glyceryl Trinitrate in Ultra-Acute Stroke: The Rapid Intervention With Glyceryl Trinitrate in Hypertensive Stroke Trial (RIGHT, ISRCTN66434824) , 2013, Stroke.
[15] P. Sandercock. Effect of thrombolysis with alteplase within 6 h of acute ischaemic stroke on long-term outcomes (the third International Stroke Trial [IST-3]): 18-month follow-up of a randomised controlled trial , 2013, The Lancet Neurology.
[16] M. Woodward,et al. Rapid blood-pressure lowering in patients with acute intracerebral hemorrhage. , 2013, The New England journal of medicine.
[17] E. Mohammadi,et al. Barriers and facilitators related to the implementation of a physiological track and trigger system: A systematic review of the qualitative evidence , 2017, International journal for quality in health care : journal of the International Society for Quality in Health Care.
[18] D. Leys,et al. Relationship between outcome and baseline blood pressure and other haemodynamic measures in acute ischaemic stroke: data from the TAIST trial , 2006, Journal of hypertension.
[19] P. Bath,et al. A systematic review of nitric oxide donors and L-arginine in experimental stroke; effects on infarct size and cerebral blood flow. , 2005, Nitric oxide : biology and chemistry.
[20] J. Weinberger. Tinzaparin in acute ischaemic stroke (TAIST): a randomised aspirin-controlled trial. , 2003, Current cardiology reports.
[21] A. Whitehurst,et al. Plasma nitric oxide (nitrate/nitrite) levels in acute stroke and their relationship with severity and outcome. , 2003, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.
[22] G. Pitari,et al. Nitric oxide plasma levels in patients with chronic and acute cerebrovascular disorders. , 1998, Panminerva medica.
[23] J. Leonardi-Bee,et al. Nitric oxide donors (nitrates), L-arginine, or nitric oxide synthase inhibitors for acute stroke. , 2002, The Cochrane database of systematic reviews.